Latest Cash Management News

Page 20 of 26
DTI Group has delivered the initial batch of hardware for the Adelaide Metro Trams PACIS upgrade, marking a key milestone in its transit technology contract. The company reported $1.6 million in receipts for the quarter, alongside a modest cash balance of $347,000.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Mindax Limited reported a $7.75 million equity raise in Q1 2025, maintaining a solid cash position with nearly six quarters of funding available despite ongoing exploration expenditures.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.
Maxwell Dee
Maxwell Dee
30 Apr 2025
TMK Energy has successfully doubled the capacity of its Gurvantes XXXV pilot well project with three new wells, achieving record monthly gas production and securing $2.3 million in fresh capital to advance commercialisation.
Maxwell Dee
Maxwell Dee
30 Apr 2025
InteliCare Holdings reported a net operating cash outflow of AUD 447,000 for Q1 2025 but remains confident in sustaining operations through active cash management and potential capital raises.
Ada Torres
Ada Torres
30 Apr 2025
Dragon Mountain Gold Limited reports steady progress in refining exploration targets at its Avalon and Cawse Projects while evaluating new acquisitions, despite a modest cash balance of $212,000.
Maxwell Dee
Maxwell Dee
30 Apr 2025
North Stawell Minerals Ltd reported a significant reduction in cash reserves for the quarter ending March 2025, highlighting a potential capital raising as exploration activities near completion.
Maxwell Dee
Maxwell Dee
30 Apr 2025
FirstWave’s Q3 FY25 update reveals steady contract renewals alongside tighter cash reserves, as the cybersecurity firm advances strategic partnerships and operational efficiencies.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.
Ada Torres
Ada Torres
30 Apr 2025
Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.
Ada Torres
Ada Torres
30 Apr 2025
PeopleIn Limited reported a $6.3 million Q3 FY25 EBITDA, down from $6.9 million last year, affected by severe weather in Queensland. Strong cash flow helped reduce debt, underscoring resilience despite ongoing trading challenges.
Victor Sage
Victor Sage
30 Apr 2025

Browse the archive

Full archive